These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37473593)

  • 61. Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis.
    Bisecco A; Capuano R; Caiazzo G; d'Ambrosio A; Docimo R; Cirillo M; Russo A; Altieri M; Bonavita S; Rocca MA; Filippi M; Tedeschi G; Gallo A
    Mult Scler; 2021 Jan; 27(1):134-138. PubMed ID: 31793399
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.
    Meijer KA; Eijlers AJC; Geurts JJG; Schoonheim MM
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):205-210. PubMed ID: 28986469
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Grey matter atrophy in patients with benign multiple sclerosis.
    Niiranen M; Koikkalainen J; Lötjönen J; Selander T; Cajanus A; Hartikainen P; Simula S; Vanninen R; Remes AM
    Brain Behav; 2022 Jul; 12(7):e2679. PubMed ID: 35765699
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.
    Chen X; Schädelin S; Lu PJ; Ocampo-Pineda M; Weigel M; Barakovic M; Ruberte E; Cagol A; Marechal B; Kober T; Kuhle J; Kappos L; Melie-Garcia L; Granziera C
    Neuroimage Clin; 2023; 37():103349. PubMed ID: 36801600
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
    Bergsland N; Zivadinov R; Dwyer MG; Weinstock-Guttman B; Benedict RH
    Mult Scler; 2016 Sep; 22(10):1327-36. PubMed ID: 26541795
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study.
    Mallik S; Muhlert N; Samson RS; Sethi V; Wheeler-Kingshott CA; Miller DH; Chard DT
    Mult Scler; 2015 Apr; 21(4):423-32. PubMed ID: 25145689
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.
    Mina Y; Azodi S; Dubuche T; Andrada F; Osuorah I; Ohayon J; Cortese I; Wu T; Johnson KR; Reich DS; Nair G; Jacobson S
    Neuroimage Clin; 2021; 30():102680. PubMed ID: 34215150
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Longitudinal patterns of cortical thinning in multiple sclerosis.
    Tsagkas C; Chakravarty MM; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Magon S
    Hum Brain Mapp; 2020 Jun; 41(8):2198-2215. PubMed ID: 32067281
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosis.
    Doche E; Lecocq A; Maarouf A; Duhamel G; Soulier E; Confort-Gouny S; Rico A; Guye M; Audoin B; Pelletier J; Ranjeva JP; Zaaraoui W
    J Neuroradiol; 2017 Mar; 44(2):158-164. PubMed ID: 27865557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
    Filli L; Hofstetter L; Kuster P; Traud S; Mueller-Lenke N; Naegelin Y; Kappos L; Gass A; Sprenger T; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
    Mult Scler; 2012 Nov; 18(11):1577-84. PubMed ID: 22495945
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis.
    Carotenuto A; Valsasina P; Schoonheim MM; Geurts JJG; Barkhof F; Gallo A; Tedeschi G; Tommasin S; Pantano P; Filippi M; Rocca MA;
    Neurology; 2022 Nov; 99(22):e2517-e2530. PubMed ID: 36096690
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.
    Datta S; Staewen TD; Cofield SS; Cutter GR; Lublin FD; Wolinsky JS; Narayana PA; ;
    Mult Scler Relat Disord; 2015 Mar; 4(2):124-36. PubMed ID: 25787188
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability.
    Magon S; Chakravarty MM; Amann M; Weier K; Naegelin Y; Andelova M; Radue EW; Stippich C; Lerch JP; Kappos L; Sprenger T
    Hum Brain Mapp; 2014 Aug; 35(8):4193-203. PubMed ID: 24510715
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patients.
    Clarelli F; Assunta Rocca M; Santoro S; De Meo E; Ferrè L; Sorosina M; Martinelli Boneschi F; Esposito F; Filippi M
    Eur J Neurol; 2021 Aug; 28(8):2513-2522. PubMed ID: 33864731
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
    Gaetano L; Häring DA; Radue EW; Mueller-Lenke N; Thakur A; Tomic D; Kappos L; Sprenger T
    Neurology; 2018 Apr; 90(15):e1324-e1332. PubMed ID: 29540589
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
    Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of Choroid Plexus Inflammation on MRI With Clinical Disability Progression Over 5 Years in Patients With Multiple Sclerosis.
    Bergsland N; Dwyer MG; Jakimovski D; Tavazzi E; Benedict RHB; Weinstock-Guttman B; Zivadinov R
    Neurology; 2023 Feb; 100(9):e911-e920. PubMed ID: 36543575
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enlarged choroid plexus in relapsing-remitting multiple sclerosis may lead to brain structural changes through the glymphatic impairment.
    Xie Y; Zhu H; Yao Y; Liu C; Wu S; Zhang Y; Zhu W
    Mult Scler Relat Disord; 2024 May; 85():105550. PubMed ID: 38493535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.